

Fundamental dimension Equity attribute | CBGIPeer $0.000.00% Cap $1.83KP/E -0.0x QuantScore44/100 | AOLSPeer $0.00010.00% Cap $15.21KP/E -0.0x QuantScore26/100 | DZCALeader $0.0130.00% Cap $129.3KP/E -1.6x QuantScore45/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
78/100 |
63/100 |
53/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 0/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 40/100 | 43/100 |
Growth Revenue / earnings growth & margins | 25/100 | 0/100 | 33/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -1.6x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 0.0x | — | -36.1x |
Price / Sales | 0.0x | 0.0x | — |
Price / Free Cash Flow | -0.0x | -0.0x | -1.3x |
PEG ratio | 0.00 | -0.00 | 0.01 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 1 / 9 | 0 / 9 |
Altman Z-Score | -0.60 (Distress) | -356.52 (Distress) | -12.58 (Distress) |
Total debt / equity | 0.00 | 0.00 | 0.03 |
Quick ratio | 0.0x | 4.3x | 2.0x |
Interest coverage | — | -11.5x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +636.3% | -33.3% | -100.0% |
Net income growth YoY | -1148.1% | -35.4% | +98.8% |
Gross margin (TTM) | -8.0% | -38.8% | 0.0% |
Operating margin (FY) | -85.9% | -157.7% | — |
FCF margin (FY) | -36.0% | -149.8% | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +0.0% | 0.0% |
3M return | 0.0% | +0.0% | 0.0% |
6M return | 0.0% | +0.0% | 0.0% |
Year to date | 0.0% | +0.0% | +364.3% |
1Y return | 0.0% | +0.0% | +160.0% |
3Y return | 0.0% | +9900.0% | -13.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-291.23 -2912321680.4% premium | $-0.0202 -20252.0% premium | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |